AOD-9604 — 5mg per Vial

AOD-9604 is a modified fragment of human growth hormone, corresponding to the C-terminal region (amino acids 176–191) of the hGH molecule. Originally investigated as an “anti-obesity drug,” it retains the fat-metabolizing region of growth hormone while lacking the segments responsible for growth-promoting and glucose-related effects. In controlled laboratory research, AOD-9604 is studied for its role in stimulating lipolysis (the breakdown of stored fat) and inhibiting lipogenesis (the formation of new fat), without the impact on blood sugar or IGF-1 associated with full-length growth hormone — making it a compound of interest in metabolic, obesity, and body-composition research.

Important Note

AOD-9604 is not approved for human consumption, medical use, or diagnostic purposes. It is supplied strictly for laboratory research only. Handling should be performed by qualified professionals in an appropriate controlled research setting.

Dosage Reference Chart (Research Use Only)

FormSuggested Research ConcentrationExample PreparationNotesLyophilized Powder5mg per vialReconstitute with sterile or bacteriostatic waterStore dry at –20°C until useReconstituted Solution0.5–2 mg/mLDissolve to target concentration for experimentsStable at 2–8°C for 2–3 weeks; do not freeze once reconstitutedExperimental DosingVariable by studyAdjust according to study designPreclinical / literature-based models only

Features & Properties

Modified C-terminal fragment (176–191) of human growth hormone

Studied for stimulation of lipolysis and inhibition of lipogenesis

Examined for fat metabolism without impact on blood glucose or IGF-1

Investigated in metabolic, obesity, and body-composition research

Retains the fat-metabolizing region of hGH without growth-promoting segments

Supplied as lyophilized powder for maximum stability during storage and transport

Manufactured under research-grade quality standards with HPLC-verified purity ≥99%

Storage & Stability

Lyophilized: stable for up to 24 months at –20°C

Reconstituted solution: stable for 2–3 weeks at 2–8°C

Avoid repeated freeze–thaw cycles

Protect from light and moisture at all times

Usage Restrictions

For laboratory research use only

Not approved for human consumption, medical use, or diagnostic purposes

Handling should be performed by qualified professionals in controlled research settings

Store securely and keep out of reach of children

Do not handle during pregnancy or breastfeeding

Frequently Asked Questions

Q1. What does each vial contain? Each vial contains 5mg of AOD-9604, supplied as a sterile lyophilized powder.

Q2. What is the appearance of the product? A fine white to off-white lyophilized powder at the base of the vial.

Q3. How should it be stored? Before reconstitution: store at –20°C, stable up to 24 months. After reconstitution: store refrigerated at 2–8°C, stable 2–3 weeks.

Q4. How is it reconstituted? It is soluble in sterile or bacteriostatic water. Use aseptic technique during reconstitution to maintain integrity.

Q5. Is it sterile? Yes, it is manufactured and sealed under sterile laboratory conditions. Proper sterile handling is still required during reconstitution and use.

Q6. Is this product for human use? No. This compound is intended for research use only. It is not approved for medical or veterinary use.

Q7. What purity standard is used? Every batch is HPLC-verified to ≥99% purity and third-party tested.

Q8. What is the vial packaging? A clear borosilicate glass vial sealed with a butyl rubber stopper and aluminum crimp closure.

Q9. How stable is the product during shipping? The lyophilized form is stable under standard shipping conditions. Transfer to long-term storage (–20°C) immediately upon arrival.

Q10. Who can handle this product? Only qualified laboratory researchers with appropriate training in peptide handling and proper protective equipment.